BICB OTC
BioCube, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: -50.0%
3Y: -98.7%
5Y: -99.1%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$39K
+0.0% ▲
Net Income
-$39K
+0.0% ▲
EPS (Diluted)
$-0.00
+0.0% ▲
EBITDA
$189K
+0.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2009 | FY2011 | FY2012 | FY2013 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $45M | $0 | $0 | $0 | $0 |
| YoY Growth | +261.9% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $37M | $0 | $0 | $0 | $0 |
| Gross Profit | $8M | $0 | $0 | $0 | $0 |
| Gross Margin | 17.0% | — | — | — | — |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $6M | $259K | $281K | $379K | $39K |
| Operating Expenses | $11M | $259K | $281K | $379K | $39K |
| Operating Income | -$3M | -$570K | -$305K | -$379K | -$39K |
| Operating Margin | -7.6% | — | — | — | — |
| Interest Expense | $50K | $23K | $29K | $356K | $0 |
| Income Before Tax | -$4M | -$1M | -$92K | -$764K | -$39K |
| Tax Expense | $905K | $23K | $29K | $0 | $0 |
| Net Income | -$4M | -$1M | -$92K | -$764K | -$39K |
| Net Margin | -8.9% | — | — | — | — |
| EPS (Diluted) | $-2.33 | $-0.04 | $-0.00 | $-0.02 | $-0.00 |
| EBITDA | -$94K | $142K | -$90K | -$90K | $189K |
| Shares Outstanding | 2M | 25M | 29M | 31M | 86M |